A detailed history of Asset Management One Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 896,518 shares of BMY stock, worth $51.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
896,518
Previous 925,825 3.17%
Holding current value
$51.8 Million
Previous $38.4 Million 20.66%
% of portfolio
0.17%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$39.66 - $51.75 $1.16 Million - $1.52 Million
-29,307 Reduced 3.17%
896,518 $46.4 Million
Q2 2024

Jul 18, 2024

SELL
$40.25 - $52.99 $1.84 Million - $2.42 Million
-45,601 Reduced 4.69%
925,825 $38.4 Million
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $3.08 Million - $3.49 Million
-64,161 Reduced 6.2%
971,426 $52.7 Million
Q4 2023

Jan 24, 2024

SELL
$48.48 - $57.85 $3.98 Million - $4.75 Million
-82,118 Reduced 7.35%
1,035,587 $53.1 Million
Q3 2023

Oct 19, 2023

SELL
$57.89 - $64.73 $3.13 Million - $3.5 Million
-54,023 Reduced 4.61%
1,117,705 $64.9 Million
Q2 2023

Jul 31, 2023

SELL
$63.71 - $70.74 $2.07 Million - $2.3 Million
-32,479 Reduced 2.7%
1,171,728 $74.9 Million
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $797,719 - $904,794
12,140 Added 1.02%
1,204,207 $83.5 Million
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $4.46 Million - $5.28 Million
65,127 Added 5.78%
1,192,067 $85.8 Million
Q3 2022

Nov 04, 2022

SELL
$0.13 - $76.84 $322 - $190,716
-2,482 Reduced 0.22%
1,126,940 $80.1 Million
Q2 2022

Jul 29, 2022

SELL
$72.62 - $79.98 $2.03 Million - $2.23 Million
-27,904 Reduced 2.41%
1,129,422 $87 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $168,332 - $201,845
2,738 Added 0.24%
1,157,326 $84.5 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $861,994 - $1 Million
-16,073 Reduced 1.37%
1,154,588 $71.9 Million
Q3 2021

Nov 02, 2021

SELL
$59.17 - $69.31 $1.18 Million - $1.38 Million
-19,977 Reduced 1.68%
1,170,661 $69.3 Million
Q2 2021

Aug 03, 2021

SELL
$61.91 - $67.42 $1.9 Million - $2.07 Million
-30,630 Reduced 2.51%
1,190,638 $79.6 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $2.14 Million - $2.41 Million
-36,040 Reduced 2.87%
1,221,268 $77.1 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $1.88 Million - $2.13 Million
32,515 Added 2.65%
1,257,308 $77.3 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $1.57 Million - $1.74 Million
-27,372 Reduced 2.19%
1,224,793 $73.8 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $4.63 Million - $5.41 Million
-84,408 Reduced 6.32%
1,252,165 $73.6 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $550,489 - $799,989
11,864 Added 0.9%
1,336,573 $74.5 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $18.9 Million - $24.6 Million
383,715 Added 40.78%
1,324,709 $85 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $658,529 - $780,781
15,397 Added 1.66%
940,994 $47.7 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $375,968 - $415,738
-8,426 Reduced 0.9%
925,597 $42 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $81 Million - $96.6 Million
-1,795,762 Reduced 65.78%
934,023 $44.6 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $2.41 Million - $3.13 Million
49,462 Added 1.85%
2,729,785 $142 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $664,211 - $749,178
12,035 Added 0.45%
2,680,323 $166 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $1.94 Million - $2.42 Million
38,457 Added 1.46%
2,668,288 $148 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $518,547 - $596,952
8,654 Added 0.33%
2,629,831 $166 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $248,631 - $271,071
-4,148 Reduced 0.16%
2,621,177 $161 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $394,839 - $455,677
-7,149 Reduced 0.27%
2,625,325 $167 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,632,474
2,632,474 $147 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.